Cardiac Magnetic Resonance for Diagnosing and Guiding Treatment in Concealed Myocardial Rupture
- Conditions
- Early Infarct-associated Pericarditis
- Registration Number
- NCT07027683
- Lead Sponsor
- University of Pisa
- Brief Summary
looking for the incidence of concealed myocardial rupture in patients with post infarct pericarditis
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- STEMI
- Clinical diagnosis of Early infarct-associated pericarditis
Exclusion Criteria
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of Myocardial rupture 12 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie concealed myocardial rupture in post-infarct pericarditis patients?
How does cardiac magnetic resonance imaging compare to standard echocardiography for diagnosing concealed myocardial rupture?
Which biomarkers are associated with concealed myocardial rupture risk in post-infarct pericarditis patients?
What are the potential adverse events of CMR-guided treatment strategies for concealed myocardial rupture?
Are there any novel compounds or combination therapies targeting myocardial healing in post-infarct pericarditis?
Trial Locations
- Locations (1)
Università di Pisa
🇮🇹Pisa, Italy
Università di Pisa🇮🇹Pisa, Italy